tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stephen Willey, 169 are a BUY (68.7%), 75 are a HOLD (30.49%), 2 are a SELL (0.81%).
Analyst Stephen Willey, currently employed at STIFEL, carries an average stock price target met ratio of 50.26% that have a potential upside of 33.91% achieved within 220 days.
Stephen Willey’s has documented 452 price targets and ratings displayed on 49 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on XFOR, X4 Pharmaceuticals at 05-Dec-2025.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $21 was fulfilled within 1 day with a profit of $4.15 (16.5%) receiving and performance score of 165.01.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
Since 13-Jan-2022
3 years 7 months 23 days ago
(17-May-2022)
3/4 (75%)
$-0.12 (-1.96%)
12
Hold
Since 16-Dec-2021
$5
$1.52 (43.68%)
$9
3 years 7 months 27 days ago
(13-May-2022)
1/3 (33.33%)
$2.28 (83.82%)
6
Hold
Since 28-Dec-2021
$10
4 years 12 days ago
(28-Dec-2021)
1/2 (50%)
$1.09 (12.23%)
49
Hold
Since 16-Dec-2021
$40
4 years 24 days ago
(16-Dec-2021)
1/1 (100%)
$6.16 (18.20%)
3
Which stock is Stephen Willey is most bullish on?
Which stock is Stephen Willey is most reserved on?
What Year was the first public recommendation made by Stephen Willey?
